Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Direct to Consumer Communication in the Pharmaceutical Industry The Royalty Rate Report 2010: A Comprehensive Assessment of ... The Biochemistry of Drug Metabolism: Two Volume Set      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing a category Home  - Pharmaceuticals      - You are in Oncology category  Lung Cancer Breast Cancer Prostate Cancer Leukemia Lymphoma Ovarian Cancer Colon Cancer Cervical Cancer Brain Cancer Bladder Cancer   Sort by    Report Name ASC Report Name DESC Report Price ASC Report Price DESC   Sorted by Date Added Global Stem Cell and Advanced Technologies Market MarketsandMarkets.com, Nov 2009, Pages: 229 The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies The benefits of stem cell therapy are attracting an increasing number of patients The product... Prostate Cancer Therapeutics - A Global Market Perspective Bizacumen Inc., Nov 2009, Pages: 436 Growth in prostate cancer therapies can be attributed to the increase in number of prostate cancer incidences in men aged more than 60 years. Given the longevity of an average individual, and the rapi... Cancer Therapies - Global Market Opportunities Bizacumen Inc., Nov 2009, Pages: 486 Cancer therapies are geared towards controlling the growth of cancerous tumors, and preventing the spread of cancer to other organs of the body. Cancer care is becoming a prime concern among national ... Chronic Myelogenous Leukemia: New Targeted Therapies Take Aim at Gleevec Decision Resources, Inc., Aug 2009, Pages: 22 Chronic myelogenous leukemia (CML) is a rare blood cancer; nonetheless, CML treatments garner substantial revenues Despite recent advances in the treatment of this disease (most notably, targeted ther... Pipeline Insight: Colorectal Cancer - Growing Trend Towards Personalized Medicine Datamonitor, Oct 2009, Pages: 51 CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therap... Protein Kinase Therapeutics in Oncology - Where to Commercialize? Bioseeker, Oct 2009, Pages: 1442 This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed The report extensivel... Top 20 Cancer Therapy Brands Forecast Datamonitor, Oct 2009 The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer therapy sales totaled over $... Competitor Analysis: PDGF-R Agonists and Antagonists La Merie, Oct 2009, Pages: 55 The present Competitive Intelligence Report about PDGF-R agonists and antagonists provides a competitor evaluation in the field of platelet derived growth factor receptor (PDGF-R) or PDGF targeting mo... Board Reviews in Hematology and Medical Oncology CME Group, Oct 2009 The material has been prepared by medical experts specifically trained in hematology and medical oncology in conjunction with The George Washington University Medical Center to help physicians improve... Forecast Insight: Top 20 Cancer Therapy Brands Datamonitor, Sep 2009, Pages: 108 Targeted therapies will drive market growth in the wake of the cytotoxic and antihormonal patent cliff The cancer therapies market offers a high level of commercial reward to a handful of companies i... Eyelid Tumors, 2nd Edition Manson Publishing, Jan 2003, Pages: 128 This book provides a practical, superbly illustrated guide to the clinical diagnosis of eyelid tumors and the surgical procedures used for tumor excision and eyelid reconstruction. In this completely ... Launching Next Generation Oncology Products: Evolving Strategies in a Payor’s Market Business Insights, Aug 2009, Pages: 155 The emergence of a new wave of oncology products has been one of the most dramatic trends in the pharmaceutical market over the last decade Both large and small companies are making unprecedented inve... Nuclear Oncology CME Group, July 2008 The Johns Hopkins University School of Medicine Genetic alterations often indicate the risk of developing cancer and can define molecular signatures suitable for radionuclide diagnosis and therapy Onc... Lynn Sage Breast Cancer Symposium CME Group, Dec 2008 Northwestern University, Feinberg School of Medicine The Robert H Lurie Comprehensive Cancer Center of Northwestern University recently conducted the Lynn Sage Breast Cancer Symposium The 10th Annual ... Board Review in Medical Oncology CME Group, Oct 2008 The George Washington University Medical Center Robert S Siegel, MD, Course Chair The material has been prepared by medical experts specifically trained in hematology and medical oncology in conjuncti... MicroRNA Profiling in Cancer: A Bioinformatics Perspective Pan Stanford Publishing Pte. Ltd., Sep 2009, Pages: 300 The recent discovery of microRNAs - a new class of non-coding RNAs - has revolutionized modern biomedical sciences This book presents current advances in the emerging interdisciplinary field of microR... Cancer Diagnostic Technologies: Assessment of Current and Emerging Technologies, and Their Potential Market Applications Venture Planning Group, Sep 2009, Pages: 110 This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their ... Cancer Diagnostics Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks Venture Planning Group, Sep 2009, Pages: 15 The report identifies major opportunities emerging in the cancer diagnostics market during the next ten years; proposes “ideal” product models with tentative prices and operating characteristics; and ... Cancer Diagnostic Testing Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Venture Planning Group, Sep 2009, Pages: 25 This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing Leading Cancer Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants Venture Planning Group, Sep 2009, Pages: 80 This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technolo... Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		Top of page

All rights reserved. © Copyright 2009 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster